Cargando…

The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics

RATIONALE: Rodents are usually used to assess the ability of antipsychotic drugs to antagonize hyperlocomotion induced by dopamine agonists, such as the psychostimulant d-amphetamine. However, the substantial differences between rodents and humans may hinder extrapolation of experimental results to...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Staay, F. Josef, Pouzet, Bruno, Mahieu, Michel, Nordquist, Rebecca E., Schuurman, Teun
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755106/
https://www.ncbi.nlm.nih.gov/pubmed/19626314
http://dx.doi.org/10.1007/s00213-009-1599-z
_version_ 1782172433969577984
author van der Staay, F. Josef
Pouzet, Bruno
Mahieu, Michel
Nordquist, Rebecca E.
Schuurman, Teun
author_facet van der Staay, F. Josef
Pouzet, Bruno
Mahieu, Michel
Nordquist, Rebecca E.
Schuurman, Teun
author_sort van der Staay, F. Josef
collection PubMed
description RATIONALE: Rodents are usually used to assess the ability of antipsychotic drugs to antagonize hyperlocomotion induced by dopamine agonists, such as the psychostimulant d-amphetamine. However, the substantial differences between rodents and humans may hinder extrapolation of experimental results to humans. For this reason, we speculated that Göttingen miniature pigs, which show strong physiological and genetic homology with humans, might be a better model for investigating the effects of antipsychotics. To investigate this, we determined whether d-amphetamine induced hyperlocomotion in miniature pigs and whether this effect was reversible by antipsychotics. MATERIALS AND METHODS: d-Amphetamine was tested in the dose range of 0.2 to 2.0 mg kg(−1) for its ability to induce hyperactivity in the open field, and the effects of two antipsychotics, haloperidol and risperidone, on amphetamine-induced hyperactivity were examined. RESULTS: d-Amphetamine increased open-field activity at 0.2, 0.4, and 0.7 mg kg(−1) s.c. but not at higher doses. The stimulation of open-field activity induced by 0.4 mg kg(−1) s.c. d-Amphetamine was antagonized by haloperidol and risperidone (0.01 and 0.04 mg kg(−1) s.c.). CONCLUSION: d-Amphetamine-induced hyperlocomotion in miniature pigs may be a useful model for studying the effect of putative antipsychotics.
format Text
id pubmed-2755106
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer-Verlag
record_format MEDLINE/PubMed
spelling pubmed-27551062009-10-07 The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics van der Staay, F. Josef Pouzet, Bruno Mahieu, Michel Nordquist, Rebecca E. Schuurman, Teun Psychopharmacology (Berl) Original Investigation RATIONALE: Rodents are usually used to assess the ability of antipsychotic drugs to antagonize hyperlocomotion induced by dopamine agonists, such as the psychostimulant d-amphetamine. However, the substantial differences between rodents and humans may hinder extrapolation of experimental results to humans. For this reason, we speculated that Göttingen miniature pigs, which show strong physiological and genetic homology with humans, might be a better model for investigating the effects of antipsychotics. To investigate this, we determined whether d-amphetamine induced hyperlocomotion in miniature pigs and whether this effect was reversible by antipsychotics. MATERIALS AND METHODS: d-Amphetamine was tested in the dose range of 0.2 to 2.0 mg kg(−1) for its ability to induce hyperactivity in the open field, and the effects of two antipsychotics, haloperidol and risperidone, on amphetamine-induced hyperactivity were examined. RESULTS: d-Amphetamine increased open-field activity at 0.2, 0.4, and 0.7 mg kg(−1) s.c. but not at higher doses. The stimulation of open-field activity induced by 0.4 mg kg(−1) s.c. d-Amphetamine was antagonized by haloperidol and risperidone (0.01 and 0.04 mg kg(−1) s.c.). CONCLUSION: d-Amphetamine-induced hyperlocomotion in miniature pigs may be a useful model for studying the effect of putative antipsychotics. Springer-Verlag 2009-07-23 2009-11 /pmc/articles/PMC2755106/ /pubmed/19626314 http://dx.doi.org/10.1007/s00213-009-1599-z Text en © The Author(s) 2009
spellingShingle Original Investigation
van der Staay, F. Josef
Pouzet, Bruno
Mahieu, Michel
Nordquist, Rebecca E.
Schuurman, Teun
The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics
title The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics
title_full The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics
title_fullStr The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics
title_full_unstemmed The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics
title_short The d-amphetamine-treated Göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics
title_sort d-amphetamine-treated göttingen miniature pig: an animal model for assessing behavioral effects of antipsychotics
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755106/
https://www.ncbi.nlm.nih.gov/pubmed/19626314
http://dx.doi.org/10.1007/s00213-009-1599-z
work_keys_str_mv AT vanderstaayfjosef thedamphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics
AT pouzetbruno thedamphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics
AT mahieumichel thedamphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics
AT nordquistrebeccae thedamphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics
AT schuurmanteun thedamphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics
AT vanderstaayfjosef damphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics
AT pouzetbruno damphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics
AT mahieumichel damphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics
AT nordquistrebeccae damphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics
AT schuurmanteun damphetaminetreatedgottingenminiaturepigananimalmodelforassessingbehavioraleffectsofantipsychotics